The study involved 40 patients who were randomly assigned to perindopril 5-10 mg/day in combination with indapamide retard ( P+I ) 1.5 mg/day ( n = 20 ) or with hydrochlorothiazide ( P+HT ) 25 mg/day ( n = 20 ) .